Introduction
============

Laboratory services are the backbone of the modern healthcare sector ([@R1]). Diagnostic test results provide information that can be used to aid the patient, the physician and others in reaching decisions ([@R2]). The impact of laboratory testing in patient care contributes to greater than 60% of medical decisions ([@R3]). However, the analysis performed in the laboratory is subjected to variance; hence, every clinical laboratory must have adequate procedures to assure the quality of the medical results reported. The quality of tests performed in laboratory medicine must allow clinicians to practice good medicine ([@R4]--[@R6]).

Quality in laboratory medicine is the guarantee that each and every step in the total testing process (TTP) is correctly performed, thus ensuring valuable decision making and effective patient care ([@R6]). Errors can occur in any step of the process. These in turn directly lead to increased healthcare costs and decreased patient satisfaction. The impact of error during laboratory testing process can affect patient care in many ways, such as delay in reporting, unnecessary redraws, misdiagnosis, and improper treatment ([@R7]).

Evidence in recent decades proves that pre-, intra-and post-analytical processes are equally important for ensuring quality laboratory service. Thus, quality in clinical laboratories should be assured by focusing on all analytical aspects. Studies showed that the pre-analytical phase accounts for 46% to 68.2% of the errors observed during the TTP compared to 13--32% in the analytical and 19--47% in the post-analytical phases. Pre-analytical and post-analytical errors combined account for 93% of the total errors encountered in the laboratory ([@R8]--[@R10]).

Evidence showed that the risk of inappropriate care due to laboratory errors ranges from 6.4% to 12% and the incidence of further inappropriate investigations is much higher (19%) ([@R11], [@R12]). Poor laboratory performance that causes an error and delays in diagnosis, and treatment is an obstacle to optimal patient care, particularly in high volume patient care areas such as the University of Gondar (UOG) Hospital. Although a study was conducted in UOG Hospital laboratory focused on pre-analytical errors only, it did not show errors occurring during the TTP. In addition, UOG Hospital laboratory was recognized as a three-star level laboratory in the World Health Organization Regional Office for Africa accreditation system on November 18, 2011, but its level has come down to one-star level on September 1, 2015 ([@R13]). That is a big issue which questions laboratory performance.

Identifying and evaluating errors in TTP is mandatory by using a quality indicator ([@R14]). The hypothesis of this study was an inspection of the TTP using quality indicator would enable identification of critical errors at any point of laboratory procedure. In addition, persistent evidence-based identification of laboratory performance through evaluation of pre-, intra-, and post-analytical errors that undermine laboratory quality status helps to put a new strategy to minimize and control errors, and improve processes. Therefore, the aim of this study was to assess errors in TTP in the Clinical Chemistry laboratory of UOG Hospital.

Methods and Materials
=====================

**Study area**: The study was conducted at UOG Hospital laboratory. Gondar Town is located 738 km far from Addis Ababa, the capital city of Ethiopia. The town has around nine government health centers and one University Hospital. The Hospital is a tertiary level teaching Hospital that provides health services for more than 5 million inhabitants in Northwest Ethiopia. UOG Hospital has diagnostic laboratory service like Clinical Chemistry, Hematology, Microbiology, Parasitology, Serology, Urinalysis and Emergency laboratories that plays important role in teaching, research and community service. The laboratory is equipped with automated instruments in the Clinical Chemistry section, such as Mindray - BS 120 Auto Chemistry Analyzer, mini *VIDAS*^®^automated immunoassay, and Roche Diagnostics AVL 9180 Series Electrolyte Analyzers. Previously, there was laboratory information system (LIS). However, the LIS service currently is non-functional during the study period. Clinical Chemistry performs a large number of tests. These include lipid profile tests, kidney function tests, liver function tests, electrolyte profile tests, hormonal analysis, cancer markers detection, measurement of glucose and troponin. Approximately on average, 120 samples are run per day. These tests are manipulated in Clinical Chemistry with four medical laboratory scientists and two clinical chemists.

**Study design and period**: A cross-sectional study was conducted from February 1 to March 30, 2016, to assess errors in TTP in the Clinical Chemistry laboratory of UOG Hospital.

**Sample size and sampling technique**: The study included all test requests that were referred for Clinical Chemistry tests at the UOG Hospital during the study period. The total sample size of the study was the total number of requests ordered for Clinical Chemistry tests during the study period. All test requests ordered for Clinical Chemistry tests taking into account venous blood sample were included using consecutive sampling technique.

**Data collection methods and processes**: Process inspection sheets were formulated to help in the evaluation of pre-, intra-and post-analytical errors for Clinical Chemistry tests at UOG Hospital. Inspection sheets were based upon the International Federation of Clinical Chemistry (IFCC) approved quality indicators ([@R14]) and literature review of similar studies ([@R9], [@R15]--[@R18]) ([Table 1](#T1){ref-type="table"}). Nine investigators participated in this study. Training was given for all investigators. Data were collected in the Clinical Chemistry section during routine hours each day in the study period. The principal investigator has closely followed and checked the data collection process to ensure the completeness and consistency of the collected data.

###### 

Quality indicators in the pre-analytical, analytical and post-analytical phases

  ----------------------------------------------------------------------------------------------------------
  Quality indicators of pre-analytical phase
  ----------------------------------------------------------------------------------------------------------
  Number of requests with errors concerning patient name/total number of requests

  Number of requests with errors concerning hospital number/total number of requests

  Number of requests with errors concerning patient sex/total number of requests

  Number of requests with errors concerning patient age/total number of requests

  Number of requests with errors concerning physician name/total number of requests

  Number of requests with errors concerning patient clinical data/total number of requests

  Number of requests with errors concerning patient location/total number of requests

  Number of requests with errors concerning date of sampling/total number of requests

  Number of requests with errors concerning test ordered/total number of requests

  Number of requests with errors concerning time of sampling/total number of requests

  Number of samples haemolysed/total number of samples

  Number of samples lipemic /total number of samples

  Number of insufficient volume of samples/ total number of samples

  Number of samples mislabeled /total number of samples

  Number of samples with no request/total number of samples

  **Quality indicators of analytical phase**

  Number of IQC values that exceed the selected target /total quality control run

  Number of EQC exceeding the target range in EQAS-PT schemes / total number of quality control runin EQA\
  schemes

  **Quality indicators of post-analytical phase**

  Number of reports delivered outside the specified time/total number of reports

  Number of critical values not communicated/total number of reports

  Number of data transcription errors/total number of reports
  ----------------------------------------------------------------------------------------------------------

EQAS: External Quality Assessment schemes, EQC: external quality control, IQC: Internal Quality Control, IPD: Inpatient Department, OPD: Out Patient Department, PT: Proficiency Testing, UOG: University of Gondar

**Inclusion and exclusion criteria**: The study was conducted on processes at pre-, intra-and post-analytical phases. Requests which were ordered for Clinical Chemistry tests taking into account venous blood sample (serum sample) were included in the study.

Urine and other body fluids such as serous fluid, synovial fluid and cerebrospinal fluid were not included in this study. Moreover, test requests ordered for Clinical Chemistry tests only were included. Those requested analyses for Hematology, Coagulation, Serology, Urinalysis, Emergency laboratory and Microbiology were not included in this study.

**Data management and quality control**: Pre-test of the checklist was done to check clarity, acceptability, and consistency of the structured inspection sheets. The necessary correction was taken before the actual data collected. The data collection, in accordance with quality indicators, was checked by a senior laboratory technologist and the principal investigator. Close follow-up was done by the principal investigator. The filled checklist was collected after consistency and completeness were checked.

**Data analysis and interpretation**: The data were checked for completeness and entered to EPI info version 3.5.3 and transferred to Statistical Package for the Social Sciences (SPSS) version 20 (IBM Corporation, New York, United States) for analysis. Frequencies, and cross tabulations were used to summarize descriptive statistics. The data were compared using independent t-test.

**Ethical clearance**: Ethical clearance was taken from the Research and Ethical Review Committee of School of Biomedical and Laboratory Sciences, UOG. Permission letter was secured from both the medical director of the hospital and the diagnostic coordinator of UOG hospital. All the collected data were kept confidential by using codes instead of any personal identifiers. Detectable errors were linked to the responsible personnel for better patient management and quality improvement purpose.

Results
=======

According to this study, 3259 blood samples and their request papers were inspected. Of these, 2287(70.1%) were from the Outpatient Department (OPD) and 972(29.8%) were from the Inpatient Department (IPD).

**Parameters on the test request form**: The information provided on each request form was examined. Only 3(0.09 %) requisition papers were found to have complete data (a requested paper containing all the necessary information); the rest did not contain full information that they were supposed to contain. Indicators of patient information such as clinical data 3226(99%) were not filled on the test request form. However, patient\'s name, sex, age and hospital number were relatively more mentioned. The name, 1262(38.7%), and the exact address, 60(1.8%), of the requesting physicians were not specified on the test request form. Sample quality indicators on test request form, time of collection (99.3%) and date of sampling (40.1%) were missed on test request form ([Table 2](#T2){ref-type="table"}).

###### 

Frequency of missed data on routinely submitted test request forms in Clinical Chemistry laboratory at UOG Hospital from February to March 2016, Northwest Ethiopia

  Data type                          OPD N(%) ^n=2287^   IPD N(%) ^n=972^   Total N(%) ^n=3259^   Sig. (2-tailed)
  ---------------------------------- ------------------- ------------------ --------------------- -----------------
  Patient name                       0(0.0)              0(0.0)             0(0.0)                
  Hospital number                    1(0.04)             3(0.3)             4(0.1)                0.048
  Patient sex                        13(0.6)             5(0.5)             18(0.6)               0.849
  Patient age                        14(0.6)             5(0.5)             19(0.6)               0.737
  Physician name                     1006(44.0)          256(26.3)          1262(38.7)            0.000
  Patient clinical data              2269(99.2)          957(98.5)          3226(99.0)            0.049
  Patient location                   32(1.4)             28(2.9)            60(1.8)               0.000
  Date of sampling                   1072(46.9)          235(24.2)          1307(40.1)            0.000
  Test ordered                       1(0.04)             0(0.0)             1(0.03)               0.515
  Time of sampling                   2281(99.7)          956(98.4)          3237(99.3)            0.000
  Over all incomplete request form   2286(99.9)          970(99.8)          3256(99.9)            0.160

**Sample quality indicators**: The other observation made during the study period was an assessment of sample quality. Of the total number of 3259 samples submitted to the laboratory for Clinical Chemistry tests, 123(3.8%) were rejected. The most common reason for sample rejection was haemolysis, 41(1.3%), followed by the request with no sample or sample with no request, 39(1.2%), and mislabeled, 35(1.1%) ([Table 3](#T3){ref-type="table"}).

###### 

Type and frequency of reason for sample rejected in Clinical Chemistry laboratory at UOG Hospital from February to March 2016, Northwest Ethiopia.

  ----------------------------------------------------------------------------
  Parameter                                 OPD\      IPD\      Total\
                                            N(%)      N(%)      N(%)^n=3259^
  ----------------------------------------- --------- --------- --------------
  Haemolysis                                19(0.6)   22(0.7)   41(1.3)

  Lipemic sample                            4(0.1)    0(0.0)    4(0.1)

  Insufficient volume of sample             0(0.0)    2(0.1)    2(0.1)

  Mislabeled                                29(0.9)   6(0.2)    35(1.1)

  Sample with no request/request with no\   28(0.9)   11(0.3)   39(1.2)
  sample                                                        

  Test not ordered/inappropriate test       0(0.0)    2(0.1)    2(0.1)

  Total                                     80(2.5)   43(1.3)   123(3.8)
  ----------------------------------------------------------------------------

IPD: Inpatient Department, OPD: Out Patient Department, UOG: University of Gondar

**Quality indicators covering the analytical phase**: Unacceptable performances in external quality control (EQC) accounted for 18(51.4%), followed by non-conformity of internal quality control (IQC) 81(14.4%) ([Table 4](#T4){ref-type="table"}).

###### 

Error frequency of analytical phase in Clinical Chemistry laboratory at UOG Hospital from February to March 2016, Northwest Ethiopia.

          IQC N (%)    EQC N (%)   Total N (%)
  ------- ------------ ----------- -------------
  Pass    481(85.6)    17(48.6)    498(83.4)
  Fail    81(14.4)     18(51.4)    99(16.6)
  Total   562(100.0)   35(100.0)   597(100.0)

IQC: Internal Quality Control, EQC: External Quality Control

**Quality indicators in the post-analytical phase**: In the post-analytical phase, 291(9.3%) errors were observed. Excessive turnaround time (TAT), 270(8.6%), contributed to the majority of post-analytical errors followed by unreported critical value cases, 15(0.48). All critical value cases were not communicated to the concerned physician. Although this laboratory does not have functional laboratory information system (LIS) currently, manual reporting accounted for only 6(0.2%) transcription errors ([Table 5](#T5){ref-type="table"}).

###### 

Error frequency of post-analytical phase in Clinical Chemistry laboratory at UOG Hospital from February to March 2016, Northwest Ethiopia.

  ----------------------------------------------
  Parameter                      (n = 3136)\
                                 Frequency (%)
  ------------------------------ ---------------
  Excessive TAT                  270 (8.6)

  Not informed critical result   15 (0.48)

  Data transcription errors      6 (0.2)

  Total                          291 (9.3)
  ----------------------------------------------

TAT: turnaround time, UOG: University of Gondar

Pre-analytical phase was found to be error prone process among the total errors ([Table 6](#T6){ref-type="table"}).

###### 

Distribution of total testing process error frequency in the Clinical Chemistry laboratory at UOG Hospital from February to March 2016, Northwest Ethiopia.

  Phase                     Error frequency (%)   Error frequency (%)
  ------------------------- --------------------- ---------------------
  Pre-analytical\*^6518^    3379(51.8)            3379(89.6)
  Analytical\*^597^         99(16.6)              99(2.6)
  Post-analytical\*^3136^   291(9.3)              291(7.7)
  Total\*^10251^            3769(36.8)            3769(100)

The asterisk (\*) indicates denominator for each phase in the 'A' column, A: Error frequency in the pre-analytical, analytical, and post-analytical phases, B: Overall percent of errors in the three analytical phases

Discussion
==========

In this study, errors in TTP in Clinical Chemistry laboratory was assessed based on IFCC quality indicators. Currently, there is considerable emphasis on managing TTP in clinical laboratories. This supports a quantitative basis for interested parties aiming to guarantee improvement and up-to-date performance in care and processes ([@R14], [@R19]).

Accordingly, 3259 request papers submitted to the Clinical Chemistry laboratory, pre-analytical errors associated with request form accounted for 49.9% due to the omission of important data. Significantly, 3256(99.9%) request papers were incomplete lacking one or more of the required information. The only well-documented parameter appeared on all request forms in this study was the patient\'s name. This result was in line with findings from Ethiopia ([@R18]), Pakistan ([@R20]) and Ghana ([@R21]). This was not astonishing since it was very likely that the request would have been rejected if the patient\'s name was not mentioned. However, the name of the attending physician was omitted in 38.7% of test request forms observed. This figure was higher than a study conducted in Nigeria which reported 19.8% ([@R22]). The rationale behind this figure could be attributed to lack of awareness and variability of physicians attending the patient on one site since most physicians visiting the patient were interns.

Besides, this study showed that clinical data (99%) and time of sampling (99.3%) were found to be incomplete on the request forms. This result was consistent with a previous study done in a similar setting in Ethiopia ([@R18]) in which the authors stated that clinical data (97.8%) and time of sampling (100%) had been missed. This result indicated no improvement after the previous report at similar setting in Ethiopia ([@R18]) which demands extra management effort to create awareness concerning the impact of incomplete test request form on the quality of patient care.

Moreover, 40.1% of the request forms observed did not state the date of sampling. This was comparable to results obtained in a similar study conducted in Ghana (37.3%) ([@R21]), but, higher than results obtained in Nigeria (0.5%) ([@R23]). This variation could be attributed to the workload on physicians, attitudinal difference and negligence among physicians, lack of monitoring by the concerned body or improper orientation about the impact of incomplete test request form on the quality of patient care.

In our study, 3.8% samples were rejected for various reasons. This figure was lower than a study conducted in India (4.91%) ([@R19]), but higher than the rejection rate reported in Ethiopia (2.4%) ([@R18]), (1.4%) ([@R24]), Turkey (0.91%) ([@R25]) and USA (0.74%) ([@R26]). High staff turnover, the periodic influx of students, frequent job rotation of phlebotomists, increased patient flow or poor quality management system, would be the main cause of increased sample rejection.

In this study, the most common frequent cause of sample rejection was haemolysis (33.3%) which is comparable in a study conducted in Ethiopia ([@R24]), Nigeria ([@R27]) and Spain ([@R28]) which reported haemolysis as the main cause of sample rejection. Increased haemolysis observed from this study could be as a result of poor phlebotomy procedures or periodic influx of students in the institutions.

Remarkably, the second frequent reason for sample rejection was a sample with no request/request with no sample accounted for 31.7%, which is higher than the result reported in Ethiopia ([@R24]). The same figure for mislabeled samples was 28.5% in the current study. This could be due to excessive patient load (disproportionate of patients to phlebotomists), the absence of functional LIS and pneumatic tube complicated proper labeling and delivery of samples with corresponding request forms. Loss of attention and poor communication between staffs might further aggravate the problem.

In our study, a total of 16.6% analytical errors were seen as compared to an Indian report (5.07%) ([@R19]). Of these, unacceptable performance in IQC accounted for 14.4%, which could be due to the improper reconstitution of quality control (QC) material, inappropriate storage, instability of reagents or contamination or calibration drift. This figure (14.4%) was much higher than an Indian report (0.6%) of non-conformity of QC ([@R29]). The difference could be attributed to the difference in the use of QC material, operator, type of machine, environmental condition, or implementation of quality assurance system.

Unsatisfactory evidence has been found from the external agency as part of the involvement of proficiency testing program which showed EQC exceeding the target range accounted for 51.4%, indicated a need to address shortcomings related to analytical process, which is much higher as compared to a report of Spain (0.8%) ([@R30]). Instability of the instrument due to fluctuation in electricity, lack of laboratory staff training about automation and quality management system, staff turnover or frequent changes of staffs without training could be attributed to the remarkable increment in the analytical errors.

In the current study, the frequency of errors in post-analytical phase was 9.3%, almost triple than the study conducted in India (3.2%) ([@R29]). Even though, the percentage of transcription error contributes much in some literature ([@R29]), in this study, excessive TAT (8.6%) contributed to the majority of post-analytical errors. Electrical fluctuation, shortage of distilled water and workload could be the cause of not reporting results within a specified time. Manual reporting of results accounted only 0.2% transcription errors. Since it is all about the life of the human being, it does not mean that the result of this study is low.

Another important aspect of the post-analytical phase of the testing process was critical value reporting. On examination of critical value reporting, 15(0.48%) critical value cases were observed almost double in the Indian report (0.21%) ([@R19]), and none of them has been communicated to the concerned physician. Lack of functional LIS, poor awareness among laboratory staffs, missed parameter on the test request form such as patient address, attending physicians and telephone complicated in difficulty to notify within the target time. Failure to deliver a critical value notification within the indicated time could be life-threatening if the patient is left untreated. In fact, implementation of electronic LIS can improve the post-analytical phase. This might eliminate transcriptional errors and delay in results.

In general, the overall statistics showed that the error frequency was 89.6% in the pre-analytical phase, 2.6% in the analytical and 7.7% in the post-analytical phase. Results reported in the Netherlands with a certain difference to this study showed that the distribution of errors; pre-analytical 68.2%, analytical 13.3% and post-analytical 18.5% ([@R31]). This variation is difficult to explain with regard to the relative frequency of errors observed in the different phases, being different in work complexity, in the implementation of quality management system and method of error detection. Similarly, the frequency of errors may differ from institution to institution and time to time.

This study provides literature regarding the errors in the total testing process in clinical laboratories and points out errors in the TTP that affect the quality of the laboratory service. Therefore, errors detected can be prevented from recurring, thus; make better laboratory quality. As a limitation to this study, the whole story of errors in TTP can not be addressed. Hence, further in-depth study to evaluate details of errors in TTP, including pre-pre-analytical phases such as sampling, sample transportation and the like, and post-post-analytical phases should be conducted. Another limitation was the inability to assess the impacts of laboratory errors on patient health and the entire healthcare system. These can be a possible area for future research.

In conclusion, this study reported a high frequency of errors in the TTP. These indicate a need to address shortcomings related to each analytical process. Therefore, a continuous practice of assessing errors is mandatory to help in devising corrective strategies. This helps to improve laboratory performance and hence effective clinical decision-making process.
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